Announcements Trials
Browse Landscape

Status

Terminated 1Suspended 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 5Observational 4

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Colonic Neoplasms 3Rectal Neoplasms 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Kidney Neoplasms 2Wilms Tumor 1Unspecified Childhood Solid Tumor, Protocol Specific 1Tuberous Sclerosis 1Thyroid Neoplasms 1Spinal Cord Neoplasms 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Lymphangioleiomyomatosis 1

Interventions

Surveys and Questionnaires 34Blood Specimen Collection 24enzalutamide 18Radiotherapy 15Docetaxel 15Biopsy 14Abiraterone Acetate 14apalutamide 13Leuprolide 13Interviews as Topic 13Observation 12Magnetic Resonance Spectroscopy 12Watchful Waiting 10radium Ra 223 dichloride 9darolutamide 9Androgen Antagonists 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Radiosurgery 7Magnetic Resonance Imaging 7Brachytherapy 7abiraterone 6Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6Triptorelin Pamoate 5Standard of Care 5Positron Emission Tomography Computed Tomography 5Gonadotropin-Releasing Hormone 5Focus Groups 5Registries 4Radiotherapy, Intensity-Modulated 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Prostatic Neoplasms × Genetic Testing × Clear all
NCT04254133 2026-01-30

GIFTS

Fred Hutchinson Cancer Center

Enrolling by invitation
1,360 enrolled
Genitourinary

Prostatic Neoplasms

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Terminated
799 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03694483 2025-08-22

Prostasomes as Diagnostic Tool for Prostate Cancer Detection

Hackensack Meridian Health

Suspended
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT03934606 2025-04-10

Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

Abramson Cancer Center at Penn Medicine

Completed
1,488 enrolled
GastrointestinalGenitourinary

Pancreatic Neoplasms, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡